Device Trial Radar · NCT04027335
Use of the Leva Pelvic Digital Health System in Women With Fecal Incontinence
Last checked: Nov 19, 2026Latest source record: Jan 20, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
31
Actual
Start
Aug 27, 2019
Primary completion
Dec 21, 2020
Study completion Apr 30, 2021
Sponsor
- Lead sponsor
- Renovia, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 19, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years, up to 89 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Pilot study to understand the impact of a digital health system, including a phone app and a vaginal probe to treat fecal incontinence in women
Conditions
- Fecal Incontinence
Interventions
levaDevice
Vaginal device used for pelvic floor muscle exercises
Primary outcomes
What the sponsor says the trial is designed to measure.
- St. Mark's Incontinence ScoreTime frame: Baseline to 10 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Alabama
Birmingham, Alabama
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.